Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurotoxicity research

• Publication date

  2017-11-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12640-017-9839-1PMID 29134561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ER stress and impaired autophagy flux in neuronal degeneration and brain injury.

  2017cited by this paper
• (Neuro)degenerated Mitochondria-ER contacts.

  2017cited by this paper
• Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients.

  2017cited by this paper
• High in vivo platelet activity in female fibromyalgia patients

  2016cited by this paper
• Cannabinoid receptor ligands prevent dopaminergic neurons death induced by neurotoxic, inflammatory and oxidative stimuli in vitro

  2016cited by this paper
• Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.

  2015cited by this paper
• Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice

  2015cited by this paper
• Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions

  2015cited by this paper
• Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures

  2015cited by this paper
• Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

  2014cited by this paper
• Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases

  2014cited by this paper
• Endoplasmic reticulum stress is accompanied by activation of NF-κB in amyotrophic lateral sclerosis.

  2014cited by this paper
• Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

  2014cited by this paper
• Why do cannabinoid receptors have more than one endogenous ligand?

  2012cited by this paper
• The role of ER stress-induced apoptosis in neurodegeneration.

  2012cited by this paper
• Different approaches, one target: understanding cellular mechanisms of Parkinson's and Alzheimer's diseases.

  2012cited by this paper
• Activation of the Unfolded Protein Response Is an Early Event in Alzheimer’s and Parkinson’s Disease

  2012cited by this paper
• Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.

  2012cited by this paper
• An insight into the role of autophagy in cell responses in the aging and neurodegenerative brain.

  2012cited by this paper
• Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress

  2012cited by this paper
• Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.

  2012cited by this paper
• Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation

  2011cited by this paper
• Opposing effects of cannabinoids and vanilloids on evoked quantal release at the frog neuromuscular junction.

  2010cited by this paper
• Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?

  2010cited by this paper
• Does neuroinflammation fan the flame in neurodegenerative diseases?

  2009cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity.

  2007cited by this paper
• Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity

  2007cited by this paper
• Cannabinoids and Gliomas

  2007cited by this paper
• Cannabinoids and Neuroprotection in Basal Ganglia Disorders

  2007cited by this paper
• Activation of double‐stranded RNA‐activated protein kinase by mild impairment of oxidative metabolism in neurons

  2007cited by this paper
• Endocannabinoids and neurodegenerative diseases.

  2007cited by this paper
• Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis

  2007cited by this paper
• The unfolded protein response

  2006cited by this paper
• Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.

  2005cited by this paper
• Anandamide as an intracellular messenger regulating ion channel activity.

  2005cited by this paper
• Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

  2005cited by this paper
• Cannabinoids: between neuroprotection and neurotoxicity.

  2005cited by this paper
• Cannabinoid Receptor-induced Neurite Outgrowth Is Mediated by Rap1 Activation through Gαo/i-triggered Proteasomal Degradation of Rap1GAPII*

  2005cited by this paper
• Endoplasmic reticulum stress: cell life and death decisions.

  2005cited by this paper
• Anandamide as an intracellular messenger regulating ion channel activity

  2005cited by this paper
• Protein aggregation and neurodegenerative disease

  2004cited by this paper
• Metal‐Catalyzed Disruption of Membrane Protein and Lipid Signaling in the Pathogenesis of Neurodegenerative Disorders

  2004cited by this paper
• Are cannabinoid drugs neurotoxic or neuroprotective?

  2004cited by this paper
• Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts

  2003cited by this paper
• 'Unfolding' pathways in neurodegenerative disease.

  2003cited by this paper
• Neurons on cannabinoids: dead or alive?

  2003cited by this paper
• Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response.

  2002cited by this paper
• Acute neuronal injury, excitotoxicity, and the endocannabinoid system

  2002cited by this paper
• Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1

  2002cited by this paper
• Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor.

  2002cited by this paper
• Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide

  2002cited by this paper
• Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.

  2002cited by this paper
• Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity

  2001cited by this paper
• An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

  2001cited by this paper
• Cannabinoids and neuroprotection

  2001cited by this paper
• An endoplasmic reticulum‐specific stress‐activated caspase (caspase‐12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus

  2001cited by this paper
• Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.

  2001cited by this paper
• Cross-Talk between Two Cysteine Protease Families

  2000cited by this paper
• Extracellular-signal-regulated kinase signalling in neurons.

  1999cited by this paper
• PC12 and neuro 2a cells have different susceptibilities to acetylcholinesterase–amyloid complexes, amyloid25–35 fragment, glutamate, and hydrogen peroxide

  1999cited by this paper
• Molecular basis of the neurodegenerative disorders.

  1999cited by this paper
• Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).

  1999cited by this paper
• Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.

  1999cited by this paper
• Amyloid Formation by Mutant Huntingtin: Threshold, Progressivity and Recruitment of Normal Polyglutamine Proteins

  1998cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

  1995cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• CB1 Receptor Agonist ACEA Resists ER Stress-Mediated Apoptosis via CB1R-Independent Mechanism.

  2025cites this paper
• Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress

  2024cites this paper
• CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies

  2024cites this paper
• Cannabinoid-1 receptor activation modulates lipid mobilization and adipogenesis in the adipose tissue of dairy cows.

  2023cites this paper
• Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

  2023cites this paper
• Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease

  2022cites this paper
• Potential Neuroprotective Effect of Cannabinoids in Covid-19 Patients.

  2022cites this paper
• Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson’s Disease: A Novel and Futuristic Approach

  2022cites this paper
• Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

  2022cites this paper
• The role of hypothalamic endoplasmic reticulum stress in schizophrenia and antipsychotic-induced weight gain: A narrative review

  2022cites this paper
• Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes

  2022cites this paper
• Chronic unpredictable stress during adolescence protects against adult traumatic brain injury-induced affective and cognitive deficits.

  2021cites this paper
• The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization.

  2021cites this paper
• Cannabis and Autoimmunity: Possible Mechanisms of Action

  2021cites this paper
• Role of the TRPV Channels in the Endoplasmic Reticulum Calcium Homeostasis

  2020cites this paper
• Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: Focus on the actions of cannabinoids

  2020cites this paper
• The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases

  2019cites this paper
• Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.

  2019cites this paper
• Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?

  2019cites this paper
• Capsaicin: Physicochemical properties, cutaneous reactions and potential applications in painful and inflammatory conditions

  2019cites this paper
• Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture

  2019cites this paper
• Cannabinoid receptor 2 deletion deteriorates myocardial infarction through the down-regulation of AMPK-mTOR-p70S6K signaling-mediated autophagy

  2019cites this paper
• Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation

  2019influential citation
• Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation

  2018cites this paper
• cannabinoid receptor cb1 activation in vivo leads to corneal wound healing after chemical iinjury via specific receptor vanilloid trpv1 desensitization

  2018cites this paper
• Anandamide Effects in a Streptozotocin-Induced Alzheimer’s Disease-Like Sporadic Dementia in Rats

  2018cites this paper